Martin Shkreli Faces Fraud And Conspiracy Charges

Turing Pharmaceutical CEO and former hedge fund manager Martin Shkreli has been indicted by federal officers in a multimillion dollar scheme related to his former company, Retrophin.

Turing Pharmaceutical CEO and former hedge fund manager Martin Shkreli has been indicted by federal officers in a multimillion dollar scheme related to his former company, Retrophin.

More in Operations